228 related articles for article (PubMed ID: 18304793)
1. Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions.
Economidou F; Antoniou KM; Tzanakis N; Sfiridaki K; Siafakas NM; Schiza SE
Respir Med; 2008 May; 102(5):774-9. PubMed ID: 18304793
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-2 levels are elevated in exudative pleural effusions.
Kalomenidis I; Kollintza A; Sigala I; Papapetropoulos A; Papiris S; Light RW; Roussos C
Chest; 2006 May; 129(5):1259-66. PubMed ID: 16685017
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor levels in post-CABG pleural effusions are associated with pleural inflammation and permeability.
Kalomenidis I; Stathopoulos GT; Barnette R; Papiris S; Blackwell TS; Roussos C; Light RW
Respir Med; 2007 Feb; 101(2):223-9. PubMed ID: 16854577
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
[TBL] [Abstract][Full Text] [Related]
6. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
Nadar SK; Blann A; Beevers DG; Lip GY
J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
[TBL] [Abstract][Full Text] [Related]
7. [VEGF (vascular endothelial growth factor) concentration in serum and pleural fluid of patients with pleural malignancy and pleural tuberculosis].
Ziora D; Sielska-Spytek E; Dworniczak S; Oklek K; Kozielski J
Pneumonol Alergol Pol; 2002; 70(9-10):458-67. PubMed ID: 12710098
[TBL] [Abstract][Full Text] [Related]
8. Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer.
Economidou F; Antoniou KM; Soufla G; Lasithiotaki I; Karagiannis K; Lymbouridou R; Proklou A; Spandidos DA; Siafakas NM
J Recept Signal Transduct Res; 2010 Jun; 30(3):154-60. PubMed ID: 20196627
[TBL] [Abstract][Full Text] [Related]
9. [Role of c-c chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions.
Shu J; Sun G; Liu H; Liu J
Acta Oncol; 2007; 46(7):1004-11. PubMed ID: 17917830
[TBL] [Abstract][Full Text] [Related]
12. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
[TBL] [Abstract][Full Text] [Related]
13. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
14. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
15. Plasma markers of angiogenesis in pregnancy induced hypertension.
Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of vascular endothelial growth factor (VEGF) in neoplastic and tuberculosis effusions--preliminary results].
Jankowska R; Porebska I; Dyła T
Pneumonol Alergol Pol; 2002; 70(5-6):258-64. PubMed ID: 12518624
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Caine GJ; Stonelake PS; Lip GY; Blann AD
Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
[TBL] [Abstract][Full Text] [Related]
19. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
[TBL] [Abstract][Full Text] [Related]
20. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Lee KW; Lip GY; Blann AD
Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
